Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-26

Clinical Trial Update: Nano-hydroxyapatite With Potassium Nitrate in the Therapy of the Dental Sensitivity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating nano-hydroxyapatite with potassium nitrate for dentin hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nano-hydroxyapatite with potassium nitrate (nano-hydroxyapatite with potassium nitrate)

Snippet

Sponsor: Università degli Studi di Sassari | Conditions: Dentin Sensitivity | Phase 4 | Status: COMPLETED